Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 110

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses

Harfouche, Manale, AlMukdad, Sawsan, Alareeki, Asalah, Osman, Aisha M M, Gottlieb, Sami, Rowley, Jane, Abu-Raddad, Laith J, Looker, Katharine J · 2025 · Sexually Transmitted Infections

Published version of a preprint

Abstract

Objectives: Genital herpes simplex virus (HSV) type 1 and 2 infections are lifelong and can cause symptomatic genital ulcer disease (GUD). HSV-2 almost always causes sexually transmitted genital infection, while HSV-1 mainly causes oral infection but can be sexually transmitted to cause genital infection. This study estimated genital infection with both HSV types and associated GUD globally in 2020, breaking down the data by WHO region and sex for females and males. Methods: A calibrated mathematical model was employed to generate estimates for the incidence and prevalence of HSV-2 infection, genital HSV-1 infection, and GUD caused by both HSV types. Estimates for non-genital infections caused by HSV-1 were also generated. Model input was derived from a comprehensive systematic review and meta-analyses of HSV prevalence data for all WHO regions. Results: Globally in 2020 there were 25.6 million (95% uncertainty interval (UI) 23.1–29.4 million) people aged 15–49 years with new HSV-2 infections, and 519.5 million (95% UI 464.3–611.3 million), or 13.3% (95% UI 11.9–15.6%), with existing (prevalent) HSV-2 infections. In addition, there were 16.8 million (95% UI 10.6–22.4 million) people aged 15–49 years with new genital HSV-1 infections and 376.2 million (95% UI 235.6–483.5 million), or 10.2% (95% UI 6.4–13.1%), with prevalent genital HSV-1 infections. The estimated number of people aged 15–49 years with at least one episode of HSV-attributable GUD in 2020 was 187.9 million (95% UI 116.0–291.8 million) for HSV-2, and 16.7 million (95% UI 9.3–25.2 million) for HSV-1, totalling 204.6 million (95% UI 132.3–306.5 million). Conclusion: Genital HSV infections have a high incidence and prevalence worldwide, contributing to a significant GUD disease burden. New prevention and treatment measures, such as prophylactic and therapeutic HSV vaccines, are needed critically to control HSV infections and reduce the associated disease burden.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/sextrans-2024-056307

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 70

  1. 10.2471/BLT.19.237149 · DOI · Paper page
  2. Looker, 2020, The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study, BMJ Glob Health, 5, 10.1136/bmjgh-2019-001875 · DOI
  3. Silva, 2022, Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: a modeling study, PLoS Med, 19, 10.1371/journal.pmed.1003938 · DOI
  4. 10.1001/jama.2022.19061 · doi:10.1001/jama.2022.19061
  5. 10.1001/jama.2011.420 · DOI · Paper page
  6. 10.1097/OLQ.0000000000000522 · DOI
  7. 10.1086/591913 · DOI · Paper page
  8. Schiffer, 2009, Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model, Sci Transl Med, 1, 10.1126/scitranslmed.3000193 · DOI
  9. 10.1097/OLQ.0000000000001612 · doi:10.1097/olq.0000000000001612
  10. AlMukdad, 2021, Epidemiology of herpes simplex virus type 2 in Asia: a systematic review, meta-analysis, and meta-regression, Lancet Reg Health - West Pac, 12, 100176
  11. Harfouche, 2021, Epidemiology of herpes simplex virus type 2 in sub-Saharan Africa: systematic review, meta-analyses, and meta-regressions, EClinMed, 35
  12. 10.1136/sextrans-2021-054972 · DOI
  13. 10.1136/sti.2004.011619 · DOI
  14. 10.1016/S0140-6736(07)61908-4 · DOI · Paper page
  15. 10.1111/j.1552-6909.2009.01026.x · DOI
  16. 10.2165/00023210-200519040-00003 · DOI
  17. 10.1016/S1473-3099(17)30405-X · DOI · Paper page
  18. Abu-Raddad, 2008, Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa, PLoS One, 3, 10.1371/journal.pone.0002230 · DOI · Paper page
  19. 10.1016/S1473-3099(19)30470-0 · DOI
  20. 10.1136/sextrans-2017-053336 · DOI
  21. Higgins, 1993, Natural history, management and complications of herpes labialis, J Med Virol, Suppl 1, 22, 10.1002/jmv.1890410506 · doi:10.1002/jmv.1890410506
  22. 10.1111/odi.13234 · DOI
  23. 10.1016/j.antiviral.2003.09.006 · DOI · Paper page
  24. 10.1016/j.jaad.2007.06.027 · DOI · Paper page
  25. Whitley, 2018, Clinical management of herpes simplex virus infections: past, present, and future, F1000Res, 7, 10.12688/f1000research.16157.1 · DOI · Paper page
  26. Ayoub, 2019, Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions, BMC Med, 17, 10.1186/s12916-019-1285-x · DOI
  27. AlMukdad, 2023, Epidemiology of herpes simplex virus type 1 in Canada: systematic review, meta-analyses, and meta-regressions, Front Public Health, 11, 10.3389/fpubh.2023.1118249 · DOI
  28. Yousuf, 2020, Herpes simplex virus type 1 in Europe: systematic review, meta-analyses and meta-regressions, BMJ Glob Health, 5, 10.1136/bmjgh-2020-002388 · DOI
  29. 10.1055/s-0032-1332802 · DOI
  30. 10.1016/S2214-109X(16)30362-X · DOI · Paper page
  31. 10.1016/j.vaccine.2016.03.111 · DOI
  32. Looker, 2015, Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012, PLoS One, 10, 10.1371/journal.pone.0140765 · DOI · Paper page
  33. Looker, 2015, Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012, PLoS One, 10, 10.1371/journal.pone.0114989 · DOI · Paper page
  34. Alareeki, 2023, Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions, Lancet Reg Health Eur, 25, 10.1016/j.lanepe.2022.100558 · DOI
  35. AlMukdad, 2023, Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: systematic review, meta-analyses and meta-regressions, Epidemiol Infect, 151, 10.1017/S0950268823000183 · DOI
  36. Chaabane, 2019, Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions, Sci Rep, 9, 10.1038/s41598-018-37833-8 · DOI
  37. Harfouche, 2023, Epidemiology of herpes simplex virus type 2 in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions, J Med Virol, 95, 10.1002/jmv.28603 · DOI
  38. 10.1016/j.jinf.2019.07.012 · DOI
  39. 10.1093/cid/ciy562 · DOI
  40. Sukik, 2019, Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: systematic review and meta-analytics, PLoS One, 14, 10.1371/journal.pone.0215487 · DOI
  41. Ashley, 2002, Performance and use of HSV type-specific serology test kits, Herpes, 9, 38
  42. 10.1111/j.1469-0691.2004.00836.x · DOI
  43. 10.7326/0003-4819-115-7-520 · DOI
  44. 10.1136/sti.77.4.232 · DOI · Paper page
  45. 10.1016/j.jcv.2019.01.001 · doi:10.1016/j.jcv.2019.01.001
  46. 10.1136/sti.2009.036541 · DOI
  47. 10.1001/jama.2016.17138 · DOI
  48. 10.1128/JCM.40.2.407-413.2002 · DOI
  49. 10.1097/OLQ.0000000000000791 · doi:10.1097/olq.0000000000000791
  50. Borenstein M , Hedges LV , Higgins JPT , et al . Introduction to meta-analysis. Chichester, UK: John Wiley & Sons, Ltd, 2011.
  51. 10.1214/aoms/1177729756 · DOI · Paper page
  52. Schwarzer, 2007, Meta: an R package for meta-analysis, R news, 7, 40
  53. 10.1016/S0140-6736(16)30388-9 · DOI · Paper page
  54. Ayoub, 2021, Analytic Characterization of the Herpes Simplex Virus Type 2 Epidemic in the United States, 1950-2050, Open Forum Infect Dis, 8, 10.1093/ofid/ofab218 · doi:10.1093/ofid/ofab218
  55. 10.1016/j.epidem.2009.03.001 · DOI
  56. Hallett, 2006, Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti, Sex Transm Infect, 82 Suppl 1, i1, 10.1136/sti.2005.016014 · DOI · Paper page
  57. 10.1097/00002030-199902250-00012 · DOI · Paper page
  58. 10.1016/j.epidem.2014.06.001 · doi:10.1016/j.epidem.2014.06.001
  59. 10.3109/13625181003797280 · DOI
  60. 10.1016/S2214-109X(16)30135-8 · DOI · Paper page
  61. 10.1093/cid/cis891 · DOI · Paper page
  62. 10.1093/cid/cis894 · doi:10.1093/cid/cis894
  63. 10.1056/NEJM199708213370801 · DOI · Paper page
  64. 10.1056/NEJM199911043411904 · DOI · Paper page
  65. 10.1093/infdis/161.4.653 · DOI
  66. 10.1097/OLQ.0b013e3181c04dea · DOI
  67. 10.1128/CMR.00043-15 · DOI · Paper page
  68. 10.1016/j.vaccine.2017.03.074 · DOI
  69. 10.1016/j.vaccine.2017.10.084 · doi:10.1016/j.vaccine.2017.10.084
  70. Ayoub, 2020, Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses, Vaccines (Basel), 8, 10.3390/vaccines8030366 · DOI

Metadata

Authors
Harfouche, M., AlMukdad, S., Alareeki, A., Osman, A. M. M., Gottlieb, S., Rowley, J., Abu-Raddad, L. J., & Looker, K. J.
Venue
Sexually Transmitted Infections
Publisher
BMJ
Published
2024-12-10
Volume
101
Issue
4
Pages
214-223
ISSN
  • 1368-4973
  • 1472-3263
Cited by
110
References
1
Language
en
Funders
  • University of Bristol (Health Protection Research Unit (HPRU) in Behaviou, National Institute for Health Research (NIHR))
  • Qatar National Research Fund (NPRP9-040-3-008)
  • Weill Cornell Medicine - Qatar (Biomedical Research Program, Biostatistics, Epidemiology, and the Biomathematic)
  • UK Health Security Agency (N/A)
  • Qatar Research, Development, and Innovation Council (ARG01-0524-230321)
  • United States Agency for International Development (World Health Organization (Global HIV, Hepatitis a)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses. https://app.cochat.ai/papers/10.1136/sextrans-2024-056307
The paper
Harfouche, M., AlMukdad, S., Alareeki, A., Osman, A. M. M., Gottlieb, S., Rowley, J., Abu-Raddad, L. J., & Looker, K. J. (2025). Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses. Sexually Transmitted Infections. https://doi.org/10.1136/sextrans-2024-056307

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.